# Ketamine Infusion for Acute Sickle Cell Crisis in the Emergency Department

> **NCT02417298** · NA · TERMINATED · sponsor: **Billy Sin** · enrollment: 12 (actual)

## Conditions studied

- Pain
- Sickle Cell Disorder

## Interventions

- **DRUG:** Normal saline
- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT02417298
- **Lead sponsor:** Billy Sin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-11
- **Primary completion:** 2018-04-01
- **Final completion:** 2018-05-01
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Feasibility
- **Last updated:** 2018-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02417298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02417298, "Ketamine Infusion for Acute Sickle Cell Crisis in the Emergency Department". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02417298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*